已收盘 08-07 16:00:00 美东时间
-0.850
-3.00%
心血管药企Braveheart Bio上市首周大升66.7%;多只绩优股飙升!IOVA周升逾55.8%,季报营收创新高;Atlassian周升逾47%,第四财季营收同比增长27.6%>>
今天 09:48
今日重点评级关注:HC Wainwright & Co.:维持Precigen"买入"评级,目标价从14美元升至18美元;HC Wainwright & Co.:维持Sophia Genetics"买入"评级,目标价从12美元升至14美元
08-06 11:36
Piper Sandler analyst Kelsey Goodwin initiates coverage on Obsidian Therapeutics (NASDAQ:OBX) with a Overweight rating and announces Price Target of $42.
08-05 18:13